Thermo Fisher Scientific Inc. (NYSE:TMO) Plans $0.43 Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE:TMO) announced a quarterly dividend on Thursday, November 6th. Stockholders of record on Monday, December 15th will be paid a dividend of 0.43 per share by the medical research company on Thursday, January 15th. This represents a c) dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, December 15th.

Thermo Fisher Scientific has increased its dividend payment by an average of 0.2%per year over the last three years and has increased its dividend annually for the last 8 consecutive years. Thermo Fisher Scientific has a dividend payout ratio of 7.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Thermo Fisher Scientific to earn $25.56 per share next year, which means the company should continue to be able to cover its $1.72 annual dividend with an expected future payout ratio of 6.7%.

Thermo Fisher Scientific Stock Performance

Shares of NYSE TMO traded up $2.45 during trading hours on Friday, hitting $568.43. 1,416,080 shares of the stock were exchanged, compared to its average volume of 2,375,542. Thermo Fisher Scientific has a one year low of $385.46 and a one year high of $610.97. The company’s 50 day moving average is $516.99 and its 200 day moving average is $461.35. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.50 and a quick ratio of 1.11. The firm has a market capitalization of $213.56 billion, a P/E ratio of 32.85, a P/E/G ratio of 3.27 and a beta of 0.82.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 22nd. The medical research company reported $5.79 earnings per share for the quarter, topping analysts’ consensus estimates of $5.50 by $0.29. Thermo Fisher Scientific had a net margin of 15.02% and a return on equity of 16.97%. The firm had revenue of $11.12 billion during the quarter, compared to analyst estimates of $10.90 billion. During the same quarter in the previous year, the business earned $5.28 EPS. The business’s revenue was up 4.9% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. On average, research analysts expect that Thermo Fisher Scientific will post 23.28 EPS for the current year.

Thermo Fisher Scientific announced that its Board of Directors has initiated a stock repurchase program on Thursday, November 6th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the medical research company to buy up to 2.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.